Understanding Shariah Compliance in IPOs and Stocks:
Investing wisely is essential for both financial growth and ethical alignment. For those interested in making investments that comply with Islamic law, understanding the Shariah status of Initial Public Offerings (IPOs) and stocks is crucial. This article aims to provide insights into the Shariah compliance of Modern Diagnostic & Research Centre Ltd, a modern choice for ensuring that your investment choices are not only profitable but also ethical.
Table of Contents
LINKS
Explore Shariah-compliant investment opportunities with IslamicStock.
Before we dive in, consider these links to quickly open your demat account.
Our mobile app links are also available below.
- Open Demat Account:
- Visit our Website: www.IslamicStock.in
- Read our Blog: blog.islamicstock.in
- Download our App:
Analyzing The Company
Company Name: Modern Diagnostic & Research Centre Ltd
Industry: Healthcare
Listing At: BSE SME
Overview
MDRC started its operations in the year 1985 from New Railway Road, Gurugram and have become the pioneer in the field of Pathology and Imaging. The journey which started with a Lab and X-Ray machine in the beginning, has today reached a stage where MDRC today is in top league in terms of the range and quality of diagnostic facilities, with the capability to perform more than 2500 tests in house.
Modern Diagnostic & Research Centre offers complete range of diagnostic facilities in Radiology and High end Pathology.
Shariah Status
The IPO is Shariah Non-Compliant, please see below image.
IPO Timeline (Tentative Schedule)
| IPO Open Date | Dec 31, 2025 |
| IPO Close Date | Jan 02, 2026 |
| Tentative Allotment | Jan 05, 2026 |
| Initiation of Refunds | Jan 06, 2026 |
| Credit of Shares to Demat | Jan 06, 2026 |
| Tentative Listing Date | Jan 07, 2026 |
Financials
Modern Diagnostic & Research Centre Ltd. showed steady growth through FY25. For the year ended March 31, 2025, total income rose to ₹78.80 crore (₹68.67 crore in FY24), with EBITDA of ₹17.96 crore (₹11.05 crore). Profit after tax improved to ₹8.97 crore versus ₹5.79 crore a year earlier. Net worth strengthened to ₹20.73 crore (₹11.76 crore), and reserves rose to ₹9.73 crore (₹10.76 crore). Total borrowings were ₹22.09 crore at March 31, 2025 (₹20.46 crore). By June 30, 2025 (quarter), assets reached ₹77.86 crore and total income for the period was ₹22.67 crore, with PAT of ₹3.00 crore and EBITDA of ₹5.86 crore. Assets expanded from ₹49.49 crore (Mar‑24) to ₹64.57 crore (Mar‑25), reflecting balance sheet growth. Overall, the company demonstrates improving profitability, rising income and healthier net worth, while maintaining moderate leverage.
SEBI Disclaimer
Investing in IPOs involves risks. Please read the offer document carefully before investing. This article is for informational purposes only and does not constitute financial advice. Investors should consult their financial advisors before making any investment decisions.